To date, specific mechanisms of molecular resistance to anti-VEGF(R) monoclonal antibodies in HCC are not known, even if seems reasonable that they do not differ from other cancer types [67] (Figure 1). This evidence concerns the gene VEGFA and hepatocellular carcinoma.